SHREYA PATEL: Open Payments
NPI 1407635766 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 19 payments from 13 companies in 2025. Trend: 2023 $16 · 2024 $521 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| PFIZER INC. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $29 |
| ABBVIE INC. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
Products named: Ozempic, VOQUEZNA, Dexcom G6 Transmitter, VRAYLAR, FARXIGA, Cologuard Collection Kit, CAPLYTA, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
